Ue (en. Eu)
Translation into Spanish
EU/1/05/331/010 [7 transdermal patches] EU/1/05/331/011 [28 transdermal patches] EU/1/05/331/032 [20 transdermal patches] EU/1/05/331/033 [30 transdermal patches] EU/1/05/331/034 [56 transdermal patches] EU/1/05/331/035 [60 transdermal patches] EU/1/05/331/037 [90 transdermal patches].
EU/1/05/331/010 [7 parches transdérmicos] EU/1/05/331/011 [28 parches transdérmicos] EU/1/05/331/032 [20 parches transdérmicos] EU/1/05/331/033 [30 parches transdérmicos] EU/1/05/331/034 [56 parches transdérmicos] EU/1/05/331/035 [60 parches transdérmicos] EU/1/05/331/037 [90 parches transdérmicos].
Example taken from data source: EMEA_v3 Unspecified vulnerability in the LDAP (eu_ldap) extension before 2.8.18 for TYPO3 allows remote authenticated users to obtain sensitive information via unknown vectors.
Vulnerabilidad no especificada en la extensión LDAP (eu_ldap) anterior a 2.8.18 para TYPO3 permite a usuarios remotos autenticados obtener información sensible a través de vectores desconocidos.
Example taken from data source: ELRC-2503-Descripciones_vulner_v1 All this implies that it must be possible for complementary goods to be used together, which obviously presupposes that they are intended for the same consumer-public (22.01.2009, T-316/07, easyHotel, EU: T:2009:14, § 57-58; and 13.02.2014, T-380/12, Demon, EU: T:2014:76, § 37).
Todo ello implica que los productos complementarios deben ser susceptibles de ser utilizados de forma conjunta, lo que evidentemente supone que se dirijan al mismo público consumidor (22.01.2009, T-316/07, easyHotel, EU: T:2009:14, § 57-58; y 13.02.2014, T-380/12, Demon, EU: T:2014:76, § 37).
Example taken from data source: ELRC-1076-EUIPO_law_v1 The criteria to be taken into account in connection with this discretional power have been defined in several Court of Justice judgments, including PROTI SNACK (03/10/2013, C-120/12 P, Proti Snack, EU: C:2013:638, § 23), CENTROTHERM (26/09/2013, C-610/11 P, Centrotherm, EU: C:2013:912, § 109), FISHBONE (18/07/2013, C-621/11 P, Fishbone, EU: C:2013:484, § 23) and ARCOL (13/03/2007, C-29/05 P, Arcol, EU: C:2007:162, § 43).
Los criterios a tener en cuenta en relación a dicho poder discrecional han sido definidos en diversas sentencias del Tribunal, incluidas PROTI SNACK (03/10/2013, C-120/12 P, Proti Snack, EU: C:2013:638, § 23), CENTROTHERM (26/09/2013, C-610/11 P, Centrotherm, EU: C:2013:912, § 109), FISHBONE (18/07/2013, C-621/11 P, Fishbone, EU: C:2013:484, § 23) y ARCOL (13/03/2007, C-29/05 P, Arcol, EU: C:2007:162, § 43).
Example taken from data source: ELRC-1076-EUIPO_law_v1 References ==== External links ==* Pallidol on www.phenol-explorer.eu.
Referencias ==== Enlaces externos ==* Pallidol on www.phenol-explorer.eu.
Example taken from data source: Wikipedia_v1.0 Thanks to EU funds, progress in reducing the distance to the EU average is clearly visible in many countries which joined the EU in 2004.
Gracias a los fondos de la UE, el progreso en la reducción de la distancia con respecto a la media de la UE en muchos de los países que se adhirieron a la UE en 2004 es claramente visible.
Example taken from data source: ELRC-3852-Development_Funds_Re_v1 It follows that OHIM may not have regard to evidence of use that occurred after the date of filing (12/12/2002, T-247/01, Ecopy, EU: T:2002:319, § 36-37; 21/11/2012, T-338/11, Photos.com, EU: T:2012:614, § 45).
De ello se desprende que la OAMI no puede tomar en consideración cualquier elemento de prueba que se refiera al uso posterior a la fecha de presentación (12/12/2002, T-247/01, Ecopy, EU: T:2002:319, § 36-37; 21/11/2012, T-338/11, Photos.com, EU: T:2012:614, § 45).
Example taken from data source: ELRC-1076-EUIPO_law_v1